Skip to main content

ProShare Advisors LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in AKBA

as of Mar 31, 2026 · filed Apr 27, 2026
Position Value
$51,018
-$23,483 QoQ
Shares Held
36,704
-20.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ProShare Advisors LLC holds $26,488,118 across 27 Drug Manufacturers - Specialty & Generic names. AKBA ranks #24 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $51,018 36,704
2025-12-31 $74,501 46,274
2025-09-30 $116,707 42,750
2025-06-30 $186,608 51,266
2025-03-31 $90,005 46,878
2024-12-31 $111,311 58,585
2024-09-30 $51,886 39,308
2022-09-30 $4,886 15,465
2022-06-30 $5,045 14,293
2022-03-31 $36,479 50,807
2021-12-31 $141,794 62,741
2021-09-30 $171,745 59,634
2021-06-30 $266,141 70,222
2021-03-31 $201,532 59,537
2020-12-31 $151,300 54,036
2020-09-30 $102,026 40,648
2020-06-30 $547,274 40,300
2020-03-31 $176,606 23,299